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ABSTRACT 
 
The importance of nutrition in the prevention of chronic disease has been recognised for 
some time in the global community. In developing countries, the problem is sometimes 
referred to as double burden of disease, where malnutrition exists in the company of 
growing rates of lifestyle related diseases such as obesity, diabetes and cardiovascular 
disease. The frontiers of science have brought forth new understanding of the links 
between early under-nutrition and the later development of chronic lifestyle related 
disease, challenging the nutrition scientist and practitioner to evaluate practice to better 
support health throughout the life course. The observation of the impact of birth size on 
later nutritional challenges underpins the importance of maternal nutrition, not only in 
pregnancy but perhaps also in the pre- pregnancy period. Further research continues on 
the significance of subsequent nutritional practices at critical times in growth and 
development. Underpinning this understanding is the role of genetic background on 
nutritional requirements (nutrigenetics) and the effect of nutrients and food bioactives on 
genetic expression (nutrigenomics). This whole new enterprise has significant 
implications for the development of the food supply and of dietary advice to support 
health. An appreciation of the biological significance of whole foods also becomes a 
necessary parallel activity to that of consuming food in a way that matches and supports 
human health. 
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INTRODUCTION 
The importance of nutrition in the prevention of chronic disease such as obesity, 
cardiovascular disease and diabetes has been recognized for some time [1].  In 2001 
chronic disease contributed to 60% of reported deaths and 46% of the global disease 
burden, and this latter figure is expected to increase to 57% by the year 2020 [1].  Obesity 
is of prime concern, not least because of the rate at which the prevalence is increasing, 
but also because its reach extends across the globe.  Since 1980 rates have tripled in areas 
like North America, Eastern Europe, the Middle East, Australia and China
 
[2]. Likewise, 
the prevalence of diabetes is increasing, estimated at 2.8% in 2000 (171 million people) 
to 4.4% in 2030 (366million people) [3].  Linked to these conditions, cardiovascular 
disease is set to become the leading cause of death and disability, with 24 million cases 
predicted for 2030 [4].  
 
 In developing countries, nutrition related problems are sometimes referred to as a double 
burden, where obesity, diabetes, and heart disease rest in the company of malnutrition, 
usually in different locations.  For example, a prospective study of schoolchildren in the 
Gauteng province of South Africa between 1962 and 1999 saw the percent energy from 
carbohydrate decrease from 72-60% and the fat consumption increase from 17 to 25.8%.  
The urban children were more likely to change their dietary habits and be overweight, but 
micronutrient deficiency and stunting were still prevalent [5].  In addition to the nutrition 
transition phenomenon, variation is also seen in prevalence rates amongst different sub-
groups within a population.  For example, in the USA, ethnicity appears to play a major 
role in the prevalence of metabolic syndrome [6], a term used to link risk factors 
associated with overweight, diabetes and heart disease [www.diabetes-symposium.org]. 
With these issues in mind, this review considers the role of nutrition in the prevention 
chronic disease, and the implications for the development of the food supply and 
associated dietary advice. 
 
ORIGINS OF CHRONIC DISEASE 
By nature, the development of chronic disease rests in the course of events over time.  
Food directly contributes to body composition and the processes of the human biological 
system.  With the discovery of the human genome, the complexity of this 
interrelationship has become more exposed, particularly in view of the interactions 
between food components and genetic expression.  The implications are that diet is 
important at all points in time, that poor diet is likely to have a deleterious effect if 
prolonged or occurring at critical points of the development phase, and that modifications 
in diet may play a pivotal role in managing the disease process. 
 
The mechanisms by which diet influences health are complex.  They relate to 
physiological mechanisms in multiple organs and are linked to regulation at the level of 
genes, gene expression, proteins and metabolites [7].  Fatty acids, for example, are known 
to influence gene expression in relation to the development of obesity [8], and this has 
lead to considerations of lifestyle-drug therapies in the management of metabolic 
syndrome [9].  Overall, the interaction between nutrients and genes is considered to have 
a central impact on lifespan and disease development [10]. 
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The relationship, however, is not linear, with incremental environmental exposure a 
critical factor in genetic expression.  Perhaps one of the most significant observations 
here is that early exposure to food components influences long term health.  In a 
longitudinal study of 4630 males followed for 12 years in Helsinki, Finland, Barker and 
colleagues noted that low birth weight and subsequent poor growth during infancy was 
related to increased risk of developing lifestyle related disease reflective of weight gain 
[11]. A subsequent analysis of 8760 boys born between 1934 and 1944 found that later 
development of type 2 diabetes was not related to rate of infant growth following low 
birthweight (< 3.5kg), but was related following birthweight of >3.5kg if there was slow 
growth in length between birth and 3 months.  In both groups, rapid gain in BMI after 
2yrs age was associated with increased risk, and this gain was linked to socioeconomic 
factors.  Thus faltering growth may result in impaired insulin metabolism that cannot 
meet demands of subsequent increases in BMI [12].  Differences between boys and girls 
in the pathways for development of coronary heart disease (CHD) were found in a study 
4130 girls from the same cohort.  Girls who developed CHD, rather than thin, were short 
at birth, compensated for this during infancy then became thin and later developed a rapid 
increase in BMI.  Girls were seen as less vulnerable to under nutrition in utero and better 
able to compensate in an adverse post natal environment [13].  In contrast for boys, poor 
growth during infancy and small body size at 12 months was a stronger predictor of CHD 
than low birth weight [14]. 
 
The links between early growth and development of later disease have been generally 
confirmed through studies of cohorts from other parts of the globe.  In a study of 356 
Guatemalan children, positive associations were found between length at age 2 and fat 
mass, height and weight, with birth weight directly related to waist hip ratio in females 
[15]. Research on persons conceived during the 1944-45 Dutch famine found an earlier 
onset of coronary artery disease compared to unexposed persons [hazard ratio adjusted 
for sex 1.9; 95%CI 1.0-3.8] [16], but a subsequent study could not confirm that this lead 
to increased adult mortality, although the cohort was only studied to 57yrs [17].  Thus, 
while early nutrition may play a role in programming disease, there appears to be 
opportunity to manage the risk later in life.  In the Herfordshire Cohort Study  [37,615 
men and women born 1911-1939] lower birth weight was associated with increased risk 
of mortality from cardiovascular disease in men and women [18].  Interestingly a 
subsequent study of a 59-71yr old subset found that high intakes of total and saturated fat 
were associated with adverse HDL:total cholesterol ratios in men with low birth weights 
(<3.2kg) (interaction effects P=0.02 for total fat and 0.01 for saturated fat, increasing to 
0.008 and 0.006 respectively with those taking cholesterol lowering medications 
excluded) [19]. This finding could be interpreted as evidence of gene nutrient 
interactions, whereby the effects of nutrients (is this case fat) are mediated by the genetic 
profile of the organism. 
 
 
The initial observations of Barker that low birthweight infants were at greater risk of 
chromic lifestyle related diseases, has helped to develop to the concept of ‘developmental 
plasticity’ in humans.  It explains how different environmental conditions during 
development can result in different physiological or morphological states from one 
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genotype [20]. More specifically, it explains how insulin resistance [21] and hypertension 
[22] may emerge in persons with low birthweight and thinness at 2yrs followed by an  
increase in BMI after 2 yrs.  The implications for growth protection during the first 2 yrs 
of life and the prevention of rapid increases in BMI after that age then represent major 
challenges for nutritional strategies for the health of populations. 
 
If we take the position that the chronic diseases such as obesity, cardiovascular disease 
and diabetes have their origins in early development, then it follows that nutrition 
intervention is important throughout the lifespan, not just at the time where risk factors 
reach a certain ‘treatable’ point.  In any case, with increasing obesity rates, these cut off 
points are working their way down from the middle aged to the young.  The term ‘adult 
onset diabetes’ is now being challenged as obese children emerge with type 2 diabetes 
mellitus, and the sequence of events leading to this situation are beginning to unfold.  
Nutrition practice will need to draw on scientific advances such as that described above 
where knowledge of a person’s nutritional history will form a part of clinical decision 
making and personalized nutrition advice will become an imperative. 
 
DEMOGRAPHIC TRENDS 
The changes in demographic trends across the globe fuel the need for prevention of 
morbidities associated with chronic lifestyle related disease.  Life expectancy will 
increase in all sectors and the percentage of the population aged over 65 yrs is expected 
to grow substantially by 2025 [23, 24].  While the so called ‘baby boomer’ generation is 
likely to have a significant effect on health care services in Western societies, the number 
of people in the age range 20-45yrs - those likely to show early signs of lifestyle related 
disease - is significant across the globe.  In addition, while the percentage of the 
population below the age of 14yrs may be reducing, this will be reflected in the number 
of children per household who will then gain attention for health and nutrition [23, 24].  
The risk is that these children may become overfed and overweight [25], but there is also 
likely to be a concomitant desire to ensure these children receive optimum nutrition, not 
just for growth but also for cognition and performance.   
 
These trends are likely to produce demands for better quality food.  With increasing 
knowledge of the impact of nutrition on health and longevity, developments in nutrition 
research stand to influence the development of the food supply.  This represents a 
challenge for science and food marketing alike, as food standards legislation references 
the quality of the evidence that substantiates these benefits.   
 
EVIDENCE BASE 
Establishing evidence for practice has become a significant activity in nutrition, whether 
this practice relates to dietary guidelines for the general population, clinical practice 
guidelines for disease management or food standards legislation governing health claims 
on foods [26-30].  In common is the need for research in humans (preferably 
experimental but including good quality observational studies), plausible dose responses, 
explanatory mechanisms and consistency in the evidence base.  Levels of evidence tend 
to be reported as convincing, probable and possible.   
 
Nutrition in chronic disease 
In the review of the WHO Technical Report series 916, Diet, Nutrition and the 
Prevention of Chronic Diseases [1], convincing evidence was found for increasing risk of 
obesity with high intake of energy dense foods, of type 2 diabetes mellitus with the 
presence of abdominal obesity, overweight and obesity, physical inactivity and maternal 
diabetes, and of cardiovascular disease with dietary saturated (myristic and palmitic) and 
trans fatty acid, dietary sodium, high alcohol intakes and the presence of overweight and 
obesity (Table 1).  A decreased risk of developing obesity was found with high intakes of 
non-starch polysaccharides, and of fruits and vegetables and with the practice of regular 
physical activity.  Likewise, decreasing risk of type 2 diabetes mellitus was found with 
voluntary weight loss and regular physical activity, whereas decreasing risk was found 
for cardiovascular disease, with intakes of linoleic acid and fish oils (and of fish itself), 
and of potassium, fruits and vegetables, with low to moderate alcohol intakes and the 
practice of regular physical activity.   
 
[INSERT TABLE 1] 
 
Put together this evidence base can be seen as a mixture of behaviors relating to physical 
activity and the consumption of some whole foods and of specific individual nutrients,  
and the presence of pre-existing conditions such as overweight/obesity, which is 
modifiable, and maternal diabetes, which is not modifiable (from the offspring’s 
perspective, although presumably it can be prevented in the mother prior to the 
conception of the child).  The evidence itself reflects the types of studies that are 
available for review, and these were not necessarily conducted for the purposes of 
establishing the evidence base.  Nevertheless, from a food/nutrient perspective, there 
appears to be enough evidence linking patterns of consumption of fatty acids, sodium and 
potassium, and fruits, vegetables and fish with the development (or not ) of chronic 
lifestyle related disease.  These dietary components could be seen as the first to emerge 
consistently in a complex picture of diet and health.   
 
Food standards and the drive for health claims related to food may forge an acceleration 
of this process.  Pre-approved health claims in Western societies have also linked reduced 
risk of cardiovascular disease with foods such as nuts and those containing wholegrains, 
fibre or soy [29]. There remain challenges, however, in communicating the degree of 
confidence the evidence base carries with respect to outcomes an individual might expect 
from including these foods in the diet. On reviewing the PASSCLAIM project outcomes 
[26] it would seem that extent of scientific support in terms of developed methodologies 
at least, was promising for foods that targeted appetite control and risk factors  for 
lifestyle related disease, but there was a need for better quality interventions (particularly 
with respect to background diet and dietary intervention modeling) and for a 
consideration of genetic factors. 
 
DIETARY FAT, FOOD AND LIFESTYLE RELATED DISEASE 
Perhaps one of the most extensively studied areas of nutrition in relation to the 
development of diet-related disease has been that of dietary fat.  Extensive mechanistic 
studies have exposed the relatively positive effects of unsaturated versus saturated fatty 
acids on insulin action [31].  The related benefits of manipulating dietary fatty acids have 
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been supported with observational and experimental studies in humans [32-35]. To be 
easily followed though, nutritional advice needs to be given in terms of foods not 
nutrients.  Our team developed research methodologies that targeted whole food sources 
of unsaturated fatty acids (in this case, walnuts) to produce desired dietary fatty acid 
profiles [36], which in turn resulted in improved lipid profiles in subjects with type 2 
diabetes mellitus [37]. Total anti-oxidant status improved significantly during the 
intervention and this was attributed to the anti-oxidants delivered concomitantly with the 
walnuts and the recommended 5 serves/day of vegetables and fruits.  In another study, the 
inclusion of walnuts and olive oil in test meals respectively was found to preserve the 
protective phenotype of endothelial cells through examinations of flow mediated 
dilatation, a quasi measure of inflammatory activity following feeding with a high fat 
meal [38]. The two studies of whole foods are significant for two reasons.  First, 
inflammation may well become the new target for nutrition strategies in the prevention of 
chronic disease [39], and positive related effects were observed with the dietary 
strategies.  Secondly, while the delivery of unsaturated fats was a primary focal point of 
each study, there was recognition of the nutrient or bioactive package that the whole food 
delivered.  Jacobs and Steffen argue that this concept of food synergy is an important 
consideration in understanding dietary exposure and the development of chronic disease 
[40].  To convert this knowledge to practice, methodologies are required to differentiate 
between foods in terms of attributes such as nutrient density [41].  Thus just as the 
evidence base for risk linking diet with disease has identified certain elements that need 
to be considered together, the experimental assessment of these elements drives us back 
to whole foods, and then to whole diets to adequately explain effects and cover all the 
known bases in disease prevention. 
 
FOOD BASED HEALTH STRATEGIES 
Translating the scientific evidence to policies and strategies for health runs in parallel to 
advances in nutritional science.  There are a number of policies in place that clearly 
outline the means by which governments and health agencies need to take action.  The 
WHO Global Strategy on diet, physical activity and health outlines the need for 
leadership, effective communication, functioning alliances and partnerships and enabling 
environments.  Strategies relate to surveillance, informed choices, standards and 
legislation, availability of healthy diets, intersectoral activity and health service provision 
[42]. In Australia, the national action agenda for children and young people and their 
families , Heathy Weight 2008 [43], outlines a matrix model of four national strategies ( 
co-ordination / capacity building, evidence / performance monitoring, whole of 
community demonstration areas, and support for families / community-wide education) 
across nine settings strategies (childcare, schools, primary care services, family / 
community care services, maternal and infant health, neighborhood / community 
organizations, workplaces, food supply, and media / marketing) (Fig 1) 
 
INSERT FIG 1 HERE 
. 
The components of these policies are reflected in the new paradigm for nutrition was 
proclaimed at the 2005 meeting of the International Union of Nutrition Scientists.  In 
view of the context in which nutrition is likely to have an impact, this new paradigm 
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called for partnerships to solve nutrition problems.  These partnership would see the 
traditional biological bases for nutrition better integrated with knowledge from the 
environmental and social sciences [44].  This broadens the potential for problem solving 
of nutrition related problems, but it will be necessary for the nutrition scientist to retain a 
discipline identity and for advances in the understanding of biological processes to be 
applied. 
 
An important consideration is the continuing acknowledgement that food lies at the heart 
of nutrition.  The European PASSCLAIM project [26]
 
provides a good example of 
productive inter sectoral engagement targeting an improved food supply
.
  This project 
integrated knowledge on marketing claims for foods with scientific methodologies and 
evidence frameworks.  The resultant framework provides those working in the field of 
food and nutrition with direction on the types of measurable effects that can be addressed 
and thereby identifies targets for the development of healthier food products.  The ability 
to lower cholesterol levels, reduce body weight, improve insulin sensitivity, reduce risk 
of type 2 diabetes are all tangible targets for food product development in the context of a 
healthy diet, based on scientific methodologies.  ILSI Europe has also produced a review 
of interventions and programmes targeting the prevention of overweight and obesity in 
children and adolescents [45], with recommendations relating to outcome measures, 
participation rates, heterogeneity in intervention groups, tailoring, changes to the physical 
and/or social environment, sustainability, impact, adverse effects and publications of 
results.  These are all positive steps to improve the scientific quality of  interventions to 
greater public good. 
 
At a policy level, the emergence of evidence frameworks for clinical practice guidelines, 
and for guidelines for disease prevention and health promotion is another significant 
development [27,30].  These developments also demonstrate the need for building our 
understanding of the way in which food and nutrition translates to health and the means 
by which we may expose it through scientific practices.   
 
CONCLUSION 
With the increasing prevalence rates of chronic disease related to lifestyle comes a more 
sophisticated view of food and nutrition.  This sees food as a biological system in itself 
comprising sets of bioactive components that interact with human biology in ways that 
can only at times be imagined.  There is much to be done, however, with the knowledge 
that is currently at hand.  The challenge lies in integrating different forms of knowledge 
and rigorously  testing the evidence that assumptions made actually hold true following 
changes in diet and physical activity.  On a broader scale, policies that govern food and 
nutrition need to be accommodating of the various sectors’ interests and contributions to 
problem solving, for example the development of dietary advice and the concomitant 
development of the food supply.  There needs to be synergy in the efforts of academia, 
government, industry and healthcare providers [46]. The advent of nutrigenomics and 
nutrigenetics heralds a new era of personalized nutrition that considers the impact of the 
nutritional environment on programming nutritional requirements and disease risk later in 
life.  One of the primary platforms for nutrition today and tomorrow will be the 
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prevention of chronic disease through an understanding of the interactions between genes 
and the nutritional environment. 
 
REFERENCES 
 
1. World Health Organisation, Diet, Nutrition and the prevention of chronic disease. 
Report of Joint WHO/FAO Expert Consultation, in WHO Technical Report Series 
916. 2003: Geneva. 
2. World Health Organization, The World Health Report 2002. Reducing risks, 
promoting healthy life. 2002, World Health Organization: Geneva. 
3. Wild, S., et al., Global prevalence of diabetes: estimates for the year 2000 and 
projections for 2030. Diab Care, 2004. 27: p. 1047-1051. 
4. World Health Organization, Atlas of heart disease and stroke. 2004, World Health 
Organization: Geneva. 
5. Ramírez-Zea, M., et al. Five-year trends in CVD risk are independent of 
schooling attainment in a prospective cohort of young Guatemalan adults. in 18th 
International Congress Nutrition 2005. Durban, South Africa: Annals of Nutrition 
and Metabolism. 
6. Earl et. al, JAMA, 2002. 287: p. 356-359. 
7. Corthesy-Theulez, I., et al., Nutrigenomics: the impact of biomics technology on 
nutrition research. Ann Nutr Metab, 2005. 49: p. 355-365. 
8. Luan J et al Evidence for gene-nutrient interaction  at the PPARR Locus. 
Diabetes,2001;50:686-689. 
9. Storlien, L., et al., Lifestyle-Gene-Drug Interactions in Relation to the Metabolic 
Syndrome, in Nutrition and Fitness: Obesity, the Metabolic Syndrome, 
Cardiovascular Disease and Cancer, A.P. Simopoulos, Editor. 2005, Karger: 
Basel. p. 84-95. 
10. Paoloni-Giacobino, A., R. Grimble, and C. Pichard, Genomic interactions with 
disease and nutrition. Clin Nutr, 2003. 22(6): p. 507-514. 
11. Barker, J.P., et al., Size at birth and resilience to effects of poor living conditions 
in adult life: a longitudinal study BMJ, 2001. 323(7324): p. 1273-1276. 
12. Eriksson, J.G., et al., Pathways of infant and childhood growth that lead to type 2 
diabetes. Diab Care, 2003. 26(11): p. 3006-10. 
13. Forsen, T., et al., Growth of girls who later develop coronary heart disease. 
Heart, 2004. 90(1): p. 20-4. 
14. Forsen, T.J., et al., The infant growth of boys who later develop coronary heart 
disease. Annals of Medicine, 2004. 36(5): p. 389-92. 
15. Li, H., et al., Associations between prenatal and postnatal growth and adult body 
size and composition. Am J Clin Nutr, 2003. 77(6): p. 1498-505. 
16. Painter, R.C., et al., Early onset of coronary artery disease after prenatal 
exposure to the Dutch famine. Am J Clin Nutr, 2006. 84(2): p. 322-7; quiz 466-7. 
17. Painter, R.C., et al., Adult mortality at age 57 after prenatal exposure to the Dutch 
famine. Eur J Epidemiol, 2005. 20(8): p. 673-6. 
18. Syddall, H.E., et al., Birth weight, infant weight gain, and cause-specific 
mortality: the Hertfordshire Cohort Study. Am J Epidemiol, 2005. 161(11): p. 
1074-80. 
Nutrition in chronic disease 
19. Robinson, S.M., et al., Combined effects of dietary fat and birth weight on serum 
cholesterol concentrations: the Hertfordshire Cohort Study. Am J Clin Nutr, 
2006. 84(1): p. 237-44. 
20. Barker, D.J.P., The developmental origins of adult disease. J Am Coll Nutr, 2004. 
23(6 Suppl): p. 588S-595S. 
21. Barker, D.J.P., The developmental origins of insulin resistance. Hormone 
Research, 2005. 64 Suppl 3: p. 2-7. 
22. Barker, D.J.P., Birth weight and hypertension. Hypertension, 2006. 48(3): p. 357-
8. 
23. Population Division of the Department of Economic and Social Affairs of the 
United Nations Secretariat. World Population Prospects.   [cited 2005 10 Mar]; 
Available from: http://esa.un.org/unpp/index.asp?panel=2. 
24. United Nations. United Nations Human Settlements Programme, Global Urban 
Observatory Section.   [cited 2005 28 Mar]; Available from: 
www.unhabitat.org/habrdd/contents.html. 
25. Magarey, A. and J. Boulton, Food intake in childhood: percentiles of food energy, 
macronutrients and selected micronutrients from infancy to eight years of age. 
MJA, 1987. 147: p. 124-127. 
26. Aggett, P.J., et al. PASSCLAIM : process for the assessment of scientific support 
for claims on foods: consensus criteria. Eur J Clin Nutr 2004 44;1:1-30. 
27. National Health and Medical Research Council. Standards and procedures for 
externally developed guidelines.  2005  [cited 2006 27 Nov]; Available from: 
http://www.nhmrc.gov.au/publications/synopses/nh56syn.htm. 
28. Richardson, D., The scientific substantiation of health claims with particular 
reference to the grading of evidence and consumer understanding. Food Science 
and Technology Bulletin: Functional Foods, 2005. 2(4): p. 39-48. 
29. United States Food and Drug Administration. Guidance for industry. Significant 
scientific agreement in the review of health claims for conventional foods and 
dietary supplements. .  1999  [cited 2005 13 Oct]; Available from: 
http://vm.cfsan.fda.gov/~dms/ssaguide.html. 
30. WCRF/AICR. Food, Nutrition and the prevention of Cancer: a global 
perspective. WCRF/AICR Expert Report  1997  [cited 2006 27 Nov]; Available 
from: http://www.wcrf-uk.org/report/preface/introduction.lasso. 
31. Storlien, LH, Baur LA Kriketos AD et al Dietary fats and insulin action. 
Diabetologia 1996;39:621-631.. 
32. Vessby, B., Uusitupa M Hermansen K et al Substituting dietary saturated fat for 
monounsaturated fat impairs insulin sensitivity in health men and women: the 
KANWU study. Diabetologia 2001,44:312-319. 
33. Salmeron, J., et al., Dietary fat intake and risk of type 2 diabetes in women. Am J 
Clin Nutr, 2001. 73: p. 1019-1026. 
34. Meyer, K.A., et al., The impact of clinical trials on the treatment of diabetes 
mellitus. J Clin Endocrin Metab, 2001. 87: p. 1929-1937. 
35. Piers, L.S., et al., Dietary composition can influence patterns of regional fat loss. 
Br J Nutr, 2003. 90: p. 717-727. 
Nutrition in chronic disease 
36. Gillen, L.J., et al., Structured Dietary Advice: Incorporating Walnuts achieves 
optimal fat and energy balance in patients with type 2 diabetes mellitus. J Am 
Diet Assoc, 2005. 105(7): p. 1087-1096. 
37. Tapsell, L.C., et al., Including walnuts in a low-fat/modified-fat diet improves 
HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diab 
Care, 2004. 27(12): p. 2777-2783. 
38. Cortes, B., et al., Acute Effects of High-Fat Meals Enriched with Walnuts or Olive 
Oil on Postprandial Endothelial Function. J Am Coll Cardiol, 2006. 48(8): p. 
1666-1671. 
39. Jensen, G.L., Inflammation as the Key Interface of the Medical and Nutrition 
Universes: A Provocative Examination of the Future of Clinical Nutrition and 
Medicine. J Parenteral Enteral Nutr, 2006. 30(5): p. 453-463. 
40. Jacobs, D.R.J. and L.M. Steffen, Nutrients, foods, and dietary patterns as 
exposures in research: a framework for food synergy. Am J Clin Nutr, 2003. 
78(3): p. S508-513. 
41. Darmon, N., et al., A Nutrient Density Standard for Vegetables and Fruits: 
Nutrients per Calorie and Nutrients per Unit Cost. J Am Diet Assoc, 2005. 
105(12): p. 1881-1887. 
42. World Health Organisation, Global Strategy on Diet, Physical Activity and 
Health. 2002, World Health Organisation: Geneva. 
43. The National Obesity Task Force, Healthy Weight 2008. 2003, Australian Health 
Ministers Advisory Council: Canberra. 
44. Leitzman, C. and G. Cannon. The New Nutrition Science: Principles. in 18th 
International Congress of Nutrition. 2005. Durban, South Africa: Annals of 
Nutrition and Metabolism. 
45. Doak CM, VisscherTLS, Renders CM et al The prevention of overweight and 
obesity in children and adolescents: a review of interventions and programme. 
Obesity Reviews 2006,7:111-136.s 
46. Blackburn, G.L. and A. Walker, Science-based solutions to obesity: what are the 
roles of academia, government, industry, and health care? Am J Clin Nutr, 2005. 
82(Suppl): p. S207-210. 
 
 
Nutrition in chronic disease 
Table 1: Levels of evidence of lifestyle factors for and against conditions of the 
metabolic syndrome. Adapted from [1] 
Evidence Decreases risk Increases risk 
Convincing * Regular physical activity
a,b,c 
* High intake of non-starch 
polysaccharides (dietary 
fibre)
a
 
* Voluntary weight loss
 b 
* Fish and fish oils 
* Vegetables and fruits 
* Potassium 
* Low to moderate alcohol 
* Sedentary lifestyle
a,b
 
* High intake of 
micronutrient-poor, energy-
dense foods
 a
 
* Abdominal obesity
 b 
* Overweight/obesity
b,c
 
* Maternal diabetes
 b
 
* Palmitic and myristic acids
c
 
* Trans fat intake
c
 
* High intake of sodium
c
 
* Excess alcohol
c
 
Probable * Environments that support 
health food choices for 
children
a
 
* Breastfeeding
a,b
 
* Non-starch 
polysaccharides
b,c 
* alpha linolenic acid
c
 
* oleic acid
c
 
* wholegrain cereals
c
 
* unsalted nuts
c
 
* plant stanols and sterols
c
 
* folate
c
 
 
* Heavy marketing of fast-
food outlets and energy-dense 
foods
 a
 
* Fruit juices and sugar-
sweetened drinks
 a
 
* Difficult social and 
economic conditions
 a
 
* Saturated fats
 b
 
* Intrauterine growth 
retardation
 b
 
* Diary cholesterol
c
 
* Unfiltered coffee (boiled)
c
 
Possible * Low Glycaemic index 
foods
a,b
 
* Omega-3 fats
b
 
* Flavonoids
c
 
* Soy products
c
 
* Large portion sizing
a
 
* A large proportion of foods 
prepared outside the home
 a
 
* Eating patterns such as rigid 
restraint or periodic 
disinhibition
 a
 
* Fat intake (total)
 b
 
* Trans fat intake
 b 
* Lauric acid-rich fats
c
 
* Impaired foetal nutrition
c
 
* Beta-carotene 
supplementation
c
 
Insufficient * Increased frequency of 
eating
 a
 
* Vitamin E
 b
 
* Chromium
 b
 
* Magnesium
 b,c
 
* Moderate alcohol
 b 
* Calcium
c
 
* Vitamin C
c
 
* Excess alcohol
 a,b
 
* Carbohydrates
c
 
* Iron
c
 
Related to 
a
 Overweight/Obesity, 
b
 Type 2 Diabetes Mellitus, 
c
 Cardiovascular disease 
 
Nutrition in chronic disease 
Figure 1: National and setting-based action strategies for children and young people 
Adapted from [43]. 
 
 
